Acrolein and Neuro Disorders

By Weinhold, Bob | Environmental Health Perspectives, February 2011 | Go to article overview

Acrolein and Neuro Disorders


Weinhold, Bob, Environmental Health Perspectives


Neurologic disorders are among the leading causes of death and illness in the United States. Their causes are poorly understood, but one of the emerging suspected culprits is the substance acrolein, which tends to be significantly elevated in the brains or spinal cords of people who have Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis (ALS), and other neurologic disorders. (1-4) A new study adds multiple sclerosis (MS) to the list of disorders potentially affectedA by this substance. (5)

Acrolein is produced naturally in the body as a by-product of membrane lipid peroxidation. It also occurs in combustion by-products such as vehicle exhaust, industrial emissions, oil- and coal-fired power plant emissions, cooking fumes, and the smoke from burning cigarettes, wood, and plastics. It's used as a biocide and to manufacture other chemicals and products such as chemical weapons. The U.S. Environmental Protection Agency (EPA) has determined the ubiquitous pollutant is a major source of respiratory damage. (6) But information on the neurologic effects of environmental acrolein is scant.

In the new study, Riyi Shi of Purdue University and colleagues injected mice with substances known to induce experimental autoimmune encephalomyelitis, an animal model for MS. (5) Within 2 weeks acrolein--lysine adduct levels in the spinal cord began to rise, peaking at 65% higher than in controls at about day 20. At the same time, the mice began to display significant muscle control problems. Treatment with the acrolein-scavenging substance hydralazine reduced those effects to a great although not significant degree. The researchers also detected significant mitigation of damage to the myelin sheath by hydralazine.

Shi and colleagues say their study provides the first evidence that endogenous acrolein plays a key role in MS. Shi says it's plausible that environmental acrolein can act in the same genera) way: "There's no reason not to believe that the same type of damage could occur."

Richard LoPachin, a neurochemist and director of research at Montefiore Medical Center in New York, partially agrees. "Because acrolein is highly reactive with proteins at the site of exposure, it has limited distribution in the body and, therefore, limited access to the brain," he says. But acrolein is just one of many type-2 alkenes, a large family of environmental and food contaminants that includes acrylamide, methyl vinyl ketone, methyl acrylate, and 4-hydroxynonenal. LoPachin says type-2 alkenes share a common mechanism of action at nerve terminals in the brain, and he thinks the combined effects of these substances could contribute to some neurologic disorders.

Robert Kavlock, director of the EPA National Center for Computational Toxicology, says acrolein's physical properties make it difficult to assess the compound using the agency's ToxCast[TM] high-throughput chemical screening program using currently available technology. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Acrolein and Neuro Disorders
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.